Wednesday, 7 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Suven Life Sciences Ltd

NSE: SUVEN · BSE: 530239 · Healthcare · 30 announcements

Share price
₹305.55
Market cap
₹8,634 Cr
Revenue (annual)
₹7.11 Cr
Net profit (annual)
₹-276.3 Cr
P/E (TTM)
-24.5×Sector 53.1×
Promoter holding
65.47%-4.68% QoQ
FII holding
0.48%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

15:35 IST BSE
Board Meeting Date

Suven Life Sciences Board Meeting Date

Suven Life Sciences will hold a board meeting on August 6, 2026, to consider and approve its unaudited financial results for the quarter ending June 30, 2026.

12:35 IST BSE
Board Meeting Date

Suven Life Sciences Board Meeting Date

Suven Life Sciences Ltd has scheduled a board meeting on May 13, 2026, to approve audited standalone and consolidated financial results for the quarter and year ended March 31, 2026. The trading window remains closed until May 15, 2026.